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A new generation computerised metacognitive
cognitive remediation programme for schizophrenia
(CIRCuiTS): a randomised controlled trial
C. Reeder1*, V. Huddy2, M. Cella1, R. Taylor1, K. Greenwood3,4, S. Landau1† and T. Wykes1†
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Background. Cognitive remediation (CR) is a psychological therapy, which improves cognitive and social functioning in
people with schizophrenia. It is now being implemented within routine clinical services and mechanisms of change are
being explored. We designed a new generation computerised CR programme, CIRCuiTS (Computerised Interactive
Remediation of Cognition – a Training for Schizophrenia), to enhance strategic and metacognitive processing, with an
integrated focus on the transfer of cognitive skills to daily living. This large trial tested its feasibility to be delivered
in therapist-led and independent sessions, and its efﬁcacy for improved cognitive and social functioning.
Methods. A two arm single blind randomised superiority trial comparing CIRCuiTS plus treatment-as-usual (TAU)
with TAU alone in 93 people with a diagnosis of schizophrenia. Cognitive, social functioning and symptom outcomes
were assessed at pre- and post-therapy and 3 months later.
Results. 85% adhered to CIRCuiTS, completing a median of 28 sessions. There were signiﬁcant improvements in visual
memory at post-treatment (p = 0.009) and follow-up (p = 0.001), and a trend for improvements in executive function at
post-treatment (p = 0.056) in favour of the CIRCuiTS group. Community function was also differentially and signiﬁcantly
improved in the CIRCuiTS group at post-treatment (p = 0.003) but not follow-up, and was speciﬁcally predicted by
improved executive functions.
Conclusions. CIRCuiTS was beneﬁcial for improving memory and social functioning. Improved executive functioning
emerges as a consistent predictor of functional gains and should be considered an important CR target to achieve func-
tional change. A larger-scale effectiveness trial of CIRCuiTS is now indicated.
Received 20 July 2016; Revised 6 April 2017; Accepted 7 April 2017; First published online 4 September 2017
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Introduction
Cognitive dysfunction is a hallmark of a diagnosis of
schizophrenia, a good predictor of functional recovery
(Green et al. 2000) and consequently a valued treatment
target (Wykes & Spaulding, 2011). Cognitive remedi-
ation (CR) is ‘a behavioural training-based intervention
to improve cognitive processes (e.g. attention, memory,
executive functioning), with the general aim of durable
beneﬁts on community functioning’ (CREW, 2012).
Meta-analytic results demonstrate beneﬁcial effects on
cognition and functioning (Krabbendam & Aleman,
2003; McGurk et al. 2007; Wykes et al. 2011), although
generalisation to functional beneﬁts are frequently
restricted to strategy-based, rather than drill-and-
practice, CRapproaches, delivered in the context of voca-
tional rehabilitation (Wykes et al. 2011; Drake et al. 2014).
There is consensus, with some supporting evidence that
cognitive improvements are likely to bemaximised if the
CR includes (i) massed practice (i.e. highly repetitive
practice taking place on several days a week for pro-
longed periods), (ii) scaffolded learning facilitating high
success rates, and (iii) a focus on motivation (Wykes &
Reeder, 2005; Wykes & Spaulding, 2011; Vinogradov
et al. 2012). CR programmes have generally not been
purpose-built and frequently do not use evidence-based
principles to drive cognitive change, or to generalise cog-
nitive changes to functioning. The lack of an optimal,
easy-to-deliver CR programme is notable, given that
CR is increasingly being adopted in governmental
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guidelines (SIGN, 2013) and routine clinical practice
(New York State Ofﬁce of Mental Health, 2010).
Our group has developed a new generation, compu-
terised metacognitive CR programme, CIRCuiTS
[Computerised Interactive Remediation of Cognition –
a Training for Schizophrenia (Reeder & Wykes,
2010)], ﬁt for widespread clinical dissemination,
which uses evidence-based cognitive training princi-
ples, and targets functioning directly. Its focus on
developing metacognition [i.e. thinking about thinking
(Flavell, 1979)] is underpinned by a model that suggests
that the transfer of cognitive skills to daily activities
depends on metacognitive knowledge and metacogni-
tive regulation, or the ability to effectively understand
and manage one’s own cognitive processes (Wykes &
Reeder, 2005). This entails a strategy-based approach,
which is supported by studies showing that changes
in executive function (i.e. metacognitive regulation) bet-
ter predict functional change in schizophenia than
changes in other cognitive processes such as memory
(Reeder et al. 2006, 2014; Eack et al. 2009; Wykes et al.
2012).
CIRCuiTS was designed for people with a schizo-
phrenia diagnosis and developed with service user
and therapist involvement. It is delivered by a therap-
ist, supplemented by independent sessions. It is highly
acceptable to service users and clinicians (Reeder et al.
2015). An independent randomised controlled trial
comparing CIRCuiTS plus Cognitive Behavioural
Therapy for psychosis (CBTp) with social contact
plus CBTp (Drake et al. 2014) showed that CIRCuiTS
participants achieved the same symptom improve-
ments with signiﬁcantly fewer CBTp sessions and
signﬁcantly greater insight and executive
improvements.
The current randomised controlled trial (RCT) com-
pares CIRCuiTS plus treatment-as-usual (TAU) with
TAU alone in people with schizophrenia. Our objectives
were to assess (i) the feasibility of delivering CIRCuiTS
with therapist-led sessions supplemented by independ-
ent working; and (ii) the efﬁcacy of CIRCuiTS for
improved cognition and social functioning.
Method
Ethical permission reference number 08/H0807/26.
Design
A two arm randomised superiority trial comparing
CIRCuiTS plus TAU with TAU alone. Outcomes were
measured at week 0 pre-randomisation (baseline),
week 12 (post-treatment) and week 26 (follow-up).
Participants
Inclusion criteria were (i) DSM-IV diagnosis of schizo-
phrenia or schizo-affective disorder, (ii) at least 1 year’s
contact with mental health services, (iii) 17–65 years,
and (iv) performance more than one S.D. below the nor-
mative mean in working memory [digit span
(Wechsler, 1993)] and/or cognitive ﬂexibility
[Wisconsin Card Sorting Test (WCST) (Heaton et al.
1993) or Hayling Sentence Completion Test (Burgess
& Shallice, 1997)]. The protocol criterion of poor social
function was interpreted as not being in paid employ-
ment, receiving ﬁnancial beneﬁts for disability, or not
living independently, due to difﬁculties in ﬁnding an
informant for the pre-speciﬁed questionnaire. This cri-
terion was included since social functioning is a target
of the intervention and a secondary outcome.
Therefore, participants needed to show room for
improvement in this respect. Exclusion criteria were
(i) plans to change medication during the study, (ii)
substance dependence or (iii) evidence of an organic
cause to cognitive difﬁculties.
Participants were recruited across the UK South
London and Maudsley Mental Health National
Health Service (NHS) Foundation Trust. Following an
explanation of the study, written informed consent
was obtained from all participants.
Interventions
Treatment-as-usual
Routine psychiatric care provided within the UK
National Health Service, which may have taken place
within community, inpatient or rehabilitation settings.
In all settings, this is likely to include individualised
multi-disciplinary contacts such as medication review
and monitoring by a psychiatrist, regular meetings
with a mental health nurse for support, and less fre-
quently, psychological or occupational therapy, resi-
dential support with self-care, and attendance at day
centres or rehabilitation programmes.
CR programme [CIRCuiTS (Reeder & Wykes, 2010;
Reeder et al. 2015)]
CIRCuiTS is a web-based computerised CR therapy,
delivered by a therapist but supplemented with inde-
pendent sessions to facilitate massed practice. It targets
metacognition, particularly strategy use, in addition to
providing massed practice of basic cognitive functions.
The therapist facilitates motivation, metacognitive and
strategy development and generalisation of learning
by encouraging the participant to learn about and
regulate their cognitive performance and to transfer
this learning to meet real-world goals. Therapists pro-
vide additional scaffolding for CR tasks to ensure
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consistent successful performance. Independent ses-
sions involve carrying out cognitive tasks allocated
by the therapist to ensure scaffolded learning.
Real-world cognitive goals are set collaboratively,
and then CIRCuiTS tasks are used to identify cognitive
strengths and difﬁculties and factors affecting cogni-
tive performance. The primary cognitive targets are
attention, memory and executive functioning and
repetitive tasks gradually increase in difﬁculty in line
with individual highly successful performance.
Participants develop a set of personalised strategies
to improve their cognitive performance, and achieve
their goals.
The CR tasks are either ‘abstract’ (neutral content,
such as numbers, and designed to target speciﬁc cogni-
tive functions) or ‘exercises’ (cognitively complex and
ecologically valid) associated with work, social situa-
tions, cooking, shopping and travelling. (Please see
the online Supplementary material 1 for some exam-
ples). Therapists encourage participants to apply the
skills learnt to daily life and to practice in vivo, in
order to achieve their real-world goals. Thus, func-
tional outcomes are directly targeted by the therapy.
Rate of delivery
CIRCuiTS was offered at least three times a week
(maximum 12 weeks), up to 40 sessions lasting up to
an hour. Where possible, according to participants’
ability and choice, therapists encouraged them to
carry out additional independent sessions (please
see online Supplementary material 1 for further
information).
Therapists and therapy ﬁdelity
Therapists were supervised, trained graduate psychol-
ogists. A high degree of ﬁdelity is ensured using com-
puterised delivery but audio-recordings of three
sessions (from start, middle and end of therapy) for
all participants who consented to recordings (n = 28
sessions) were also rated using a modiﬁed CRT
Fidelity Scale (Stenmark, 2006) (see online
Supplementary materials 2).
Outcome measures
Participants were reimbursed £5 per hour for
assessments.
Baseline assessments
Socio-demographic and clinical variables collated from
participants, case notes and mental health workers.
Estimated premorbid full scale IQ: Wechsler Test of
Adult Reading (Wechsler, 2001).
Estimated current IQ [pro-rated (Silverstein, 1982)]:
Vocabulary and Block Design from the Wechsler
Adult Intelligence Scale – Third Edition – UK
[WAIS-III-UK (Wechsler, 1993)].
Symptoms: Positive and Negative Syndrome Scale
(Kay et al. 1987) (PANSS) (total score). A 30-item clin-
ical interview to assess symptom severity for schizo-
phrenia, administered by trained graduate
psychologists achieving high inter-rater reliability to
an expert trainer. Positive, negative, disorganised,
excited and depressed subscales were used
(Wallwork et al. 2012).
Primary outcomes
The primary point of interest was 12 weeks
(post-therapy).
Verbal working memory: Digit Span [WAIS-III-UK
(Wechsler, 1993)], a working memory task: total raw
score (high scores – good performance).
Visual memory:ReyOsterreith Complex Figure (ROCF)
(Rey, 1941; Osterreith, 1944), a visual memory test:
immediate recall raw score (high scores – good
performance).
Verbal executive function: Hayling Sentence Comple-
tion test (Burgess & Shallice, 1997), measuring
response inhibition: total scaled score (high scores –
good performance).
Visual executive function: WCST (Heaton et al. 1993),
testing abstraction and cognitive ﬂexibility: percentage
errors raw score (high scores – poor performance).
Secondary outcomes
Community functioning: Time Use Survey [UK 2000
Time Use Survey (Short, 2006)]. A semi-structured
interview recording participants’ time use, selected to
capture widely disparate clinically meaningful
increases in functional activity. Key outcome: total
hours per week over the past month spent in employ-
ment, education, voluntary work, voluntary and struc-
tured leisure activities, housework and chores,
childcare, sports and hobbies.
Symptoms: PANSS: positive, negative and disorga-
nised symptom subscales (high scores – high symptom
levels).
Sample size
Following the most recent meta-analysis (Wykes et al.
2011), the planned sample size was revised to 44 per
group allowing detection of an effect size of 0.6 or lar-
ger at post-treatment with 80% power using an inde-
pendent samples t test at the 5% signiﬁcance level.
Assuming a drop out rate of 10%, 49 participants per
group were needed.
2722 C. Reeder et al.
Randomisation and blinding
Following the initial assessment, consecutive referrals
of participants meeting inclusion criteria were allo-
cated (1:1) to CIRCuiTS plus TAU or TAU using an
online system, independently set up by the Clinical
Trials Unit, KCL. A minimisation algorithm was used
to ensure balance in terms of the gender and age
group (above and below 40 years) stratiﬁers.
Graduate psychologists blind to group assignment
conducted all assessments. All the analyses not requir-
ing group identiﬁcation were carried out blind to
allocation.
Statistical analyses
Therapy feasibility analyses (conducted by CR)
These summarised therapy adherence (number and
length of completed sessions, including independent
sessions) for all CIRCuiTS participants. We judged 20
sessions a priori to constitute a minimum therapy
course. Therapy completers and non-completers and
those who did and did not complete independent ses-
sions were compared on age, current IQ, ﬁve symptom
dimensions and the primary cognitive outcomes at
baseline using t tests or Mann–Whitney U tests.
Primary and secondary outcome group comparisons
Formal analyses were carried out on an intention-
to-treat basis by SL to evaluate the efﬁcacy of
CIRCuiTS in terms of primary and secondary out-
comes at 12 and 26 weeks.
Linear mixed models ﬁtted by maximum likelihood
(ML) simultaneously modelled the 12 and 26 week
data. The models were parameterised to provide separ-
ate group effect estimates at 12 and 26 weeks (see
Table 3) and effect estimates standardised by dividing
by respective baseline S.D.s. Models include (ﬁxed)
effects of time, trial arm and a group × time interaction.
Models always include randomisation stratiﬁers and
baseline values of the variable under investigation as
a covariate to increase power. They further conditioned
on variables that were found to predict attrition to
make more realistic assumptions regarding the missing
data mechanism. (The resulting ML estimates are valid
under the missing at random assumption). To detect
such variables empirically a logistic regression was
conducted with the dependent variable ‘missingness
of the primary outcome variables at 26 weeks’. This
used a forward selection approach (inclusion threshold
10%) to test whether any of: PANSS ﬁve factor scores,
ethnic group, employment status, estimated premorbid
and current IQ, or baseline chlorpromazine equivalent,
predicted missingness, in addition to age and gender.
PANSS excited scores and premorbid IQ were found
to be predictive and hence included as covariates in
all analysis models. Finally linear mixed models con-
tained a randomly varying intercept at the level of
the participant to account for correlation between the
two repeated measures.
Exploratory mechanism analyses
Therapy characteristics were correlated with change in
each of the four primary cognitive outcomes and com-
munity functioning over 12 weeks for CRT completers:
(i) total number of sessions completed, (ii) mean num-
ber of tasks completed per session, (iii) mean number
of strategies, rated with high usefulness, used per ses-
sion, and (iv) whether or not independent sessions
were completed.
To explore whether change in any of the cognitive
variables singly partially mediated the effect of
CIRCuiTS on the functioning outcome we followed a
Baron–Kenny approach (Baron & Kenny, 1986;
MacKinnon & Valente, 2014). We adjusted mediator
and outcome models for covariates identiﬁed in the
efﬁcacy analyses.
Results
In total 93 people were randomised between 24th May
2010 and 29th May 2012. The ﬁnal follow-up assess-
ment was on 26th November 2012 (see Fig. 1).
Participant characteristics
Randomisation was successful in balancing the trial
arms with regard to baseline variables (see Table 1).
Only four participants were completely lost to
follow-up (i.e. 4.3% at both 12 and 26 week assessment
time points, Fig. 1). 17 participants had a missing value
for at least one of the four primary outcome variables
at 26 weeks (18.3%).
CIRCuiTS feasibility
Of the seven (15%) non-completers, six completed only
one or two sessions, and one completed 16 sessions. For
all CIRCuiTS participants, the median number of ses-
sions completed was 25.5 (range 1–41). Amongst com-
pleters, the median was 27.5 (20–41), the mean session
length was 45.5 min (S.D. 10.2), a mean of 4.8 (S.D. 1.6)
tasks per session were completed and a mean of 7.1
(S.D. 4.2) useful strategies used per session.
Nine people (20%) completed at least one independ-
ent session (median 6, 1–10). Participants who com-
pleted independent sessions completed a similar
number of sessions overall (median 27.5, 20–41) to
those who did not complete independent sessions
(median 27.0, 20–40). The only signiﬁcant difference
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(t = 2.8, df = 39.6, p = 0.007), with little clinical import-
ance, between those completing independent sessions
and those who did not, was on the PANSS excited
score: independent sessions mean = 5.68, S.D. = 2.2; no
independent sessions mean = 4.44, S.D. = 0.73).
Five therapists conducted the CRT with three seeing
fewer than 10 patients. The majority of rated sessions
(18 sessions – 64.2%) were scored 7/7 on the modiﬁed
CRT Fidelity Scale and the lowest score (only three ses-
sions – 10.7%) was 5/7.
Does CIRCuiTS lead to improved cognitive and
functioning outcomes?
Table S1 (please see online Supplementary material 3)
summarises observed primary and secondary
outcomes.
Table 2 shows the results of the formal statistical
analyses. Since we had four primary outcomes, the
signiﬁcance level was adjusted (α = 0.05/4 = 0.0125).
We found signiﬁcant improvements for immediate vis-
ual memory at post-treatment (p = 0.009) and at
follow-up (p = 0.001), and a trend for improvement in
non-verbal executive functioning at post-treatment (p
= 0.056), in favour of CIRCuiTS. The secondary out-
come analyses demonstrated that CIRCuiTS partici-
pants spent signiﬁcantly more time in structured
activities at post-treatment (p = 0.003). There was
also some evidence (p = 0.049) that PANSS positive
symptoms were lower in the CIRCuiTS arm at
post-treatment.
Are aspects of therapy associated with cognitive and
functional outcomes?
More completed sessions were associated with greater
non-verbal executive improvement (r =−0.31) at 12
weeks and a larger beneﬁt for structured activity (r =
0.22). Improvement in visual memory was associated
with more tasks completed and a higher number of
useful strategies (r = 0.39 and r = 0.24 respectively).
Completion of independent sessions was not asso-
ciated with any outcome.
Does cognition mediate the CR effect on functioning?
The exploratory mediation analyses are summarised in
Table 3. Change in only one of the four primary cogni-
tive outcomes, the WCST, showed a signiﬁcant associ-
ation with increased time in structured activities at 12
weeks (estimated standardised regression coefﬁcient
−0.28, 95% CI from −0.51 to −0.06). Approximately
20% of the increase in (ln-)structured time in the
CIRCuiTS arm was mediated by a reduction in
WCST errors.
Discussion
CIRCuITS feasibility
This study demonstrates that CIRCuiTS, a new gener-
ation computerised metacognitive CR programme, is
feasible for people with a schizophrenia diagnosis
with cognitive impairment. 85% of participants offered
CIRCuiTS attended at least 20 sessions within 12
Fig. 1. Consort diagram.
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weeks. This adherence rate compares favourably with
other CR studies (Wykes et al. 2011), including compu-
terised CR (Murthy et al. 2012). Six of the seven parti-
cipants with poor adherence stopped attending after
only one or two sessions, suggesting that for most par-
ticipants engagement was achieved very quickly.
The target dose was 40 sessions but the median
number for completers was 28. The average attendance
Table 1. Participant characteristics
Characteristic
Complete sample (n = 93)
mean (S.D.)/frequency (%)
Group receiving
CIRCuiTS (n = 46)
Group not receiving
CIRCuiTS (n = 47)
Age 38.3 years (10.4 years) 38.7 years (10.1 years) 37.9 years (10.9 years)
Gender
Women 33 (35.5%) 14 (30.4%) 19 (40.4%)
Men 60 (64.5%) 32 (69.6%) 28 (59.6%)
Years in education 13.2 years (2.5 years) 13.5 years (2.6 years) 13.0 years (2.4 years)
Marital status
Single 77 (82.8%) 39 (84.8%) 38 (80.9%)
Married 7 (7.5%) 3 (6.5%) 4 (8.5%)
Separated/divorced 9 (9.7%) 4 (8.7%) 5 (10.6%)
Estimated premorbid IQ 93.5 (10.8) 94.2 (10.5) 92.8 (11.2)
Current employment
Paid or self employment 6 (6.5%) 3 (6.5%) 3 (6.4%)
Voluntary employment 16 (17.2%) 6 (13.0%) 10 (21.3%)
Unemployed 58 (62.3%) 29 (63.0%) 29 (61.7%)
Student 10 (10.8%) 6 (13.0%) 4 (8.5%)
Domestic responsibilities 2 (2.1%) 1 (2.2%) 1 (2.1%)
Other 1 (1.1%) 1 (2.2%) 0 (0.0%)
Current accommodation
Independent accommodation 52 (55.9%) 23 (50.1%) 29 (61.7%)
Staffed accommodation 24 (25.8%) 14 (30.4%) 10 (21.2%)
Unstaffed group accommodation 3 (3.2%) 1 (2.2%) 2 (4.3%)
Acute psychiatric ward 1 (1.1%) 0 (0.0%) 1 (2.1%)
Rehabiliation psychiatric ward 13 (14.0%) 8 (17.4%) 5 (10.6%)
Time since ﬁrst psychiatric contact
Less than 1 year 4 (4.3%) 1 (2.2%) 3 (6.4%)
1–5 years 16 (17.2%) 8 (17.4%) 8 (17.0%)
5–10 years 19 (20.4%) 4 (8.7%) 15 (31.9%)
More than 10 years 54 (58.1%) 33 (71.7%) 21 (44.7%)
Ethnicity
White 23 (24.7%) 13 (28.3%) 10 (21.3%)
Black 54 (58.1%) 25 (54.3%) 29 (61.7%)
Asian 6 (6.5%) 2 (4.3%) 4 (8.5%)
Mixed race 10 (10.8%) 6 (13.0%) 4 (8.5%)
PANSS
Positive 8.5 (4.5) 8.3 (4.2) 8.7 (4.8)
Negative 10.8 (4.9) 11.2 (5.2) 10.5 (4.6)
Disorganised 8.0 (3.0) 8.1 (3.3) 8.0 (2.6)
Excited 5.3 (1.8) 5.4 (2.1) 5.1 (1.6)
Depressed 6.9 (3.2) 6.9 (3.3) 6.8 (3.1)
Medication
Typical anti-psychotics 9 (9.7%) 4 (8.7%) 5 (10.6%)
Atypical anti-psychotics 82 (88.2%) 42 (91.3%) 43 (91.5%)
Risperidone 17 (18.3%) 9 (19.6%) 8 (17.0%)
Olanzapine 18 (19.4%) 9 (19.6%) 9 (19.1%)
Clozapine 30 (32.3%) 14 (30.4%) 16 (34.0%)
Chlorpromazine equivalent dosage Median 333.3 mg
(0–1920.0 mg)
Median 326.6 mg
(0–1920.0 mg)
Median 377.5 mg
(43.8–1800.0 mg)
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Table 2. Estimated treatment group effects at 12 and 26 weeks post randomisation
12 weeks 26 weeks
Outcome
z-statistic
(p value)
Estimated difference (TAU-CR)
[95% CI] Stand. effect size
z-statistic
(p value)
Estimated difference (TAU-CR)
[95% CI] Stand. effect size
Primary outcomes
Verbal working memory (Digit
span)
−1.19 (p = 0.24) −0.564 [−1.494 to 0.366] ES =−0.16 −0.99 (p = 0.32) −0.474 [−1.417 to 0.464] ES =−0.13
Visual memory (ROCF) −2.63 (p = 0.009) −2.403 [−4.194 to −0.611] ES =−0.35 −3.46 (p = 0.001) −3.166 [−4.957 to −1.374] ES =−0.46
Verbal executive function
(Hayling)
−0.65 (p = 0.52) −0.421 [−1.699 to 0.857] ES =−0.09 −0.83 (p = 0.41) −0.545 [−1.839 to 0.749] ES =−0.12
Visual executive function
(WCST)
1.91 (p = 0.056) 6.531 [−0.176 to 13.237] ES = 0.36 1.66 (p = 0.098) 5.713 [−1.046 to 12.473] ES = 0.32
Secondary outcomes
Time spend in structured
activitiesa
−3.01 (p = 0.003) 0.622a [0.457–0.847]a ES =−0.55 −0.42 (p = 0.67) 0.936a [0.687–1.276]a ES =−0.08
Positive symptomsa (PANSS) 1.97 (p = 0.049) 1.129a [1.001–1.275]a ES = 0.24 0.26 (p = 0.80) 1.016a [0.899–1.149]a ES = 0.03
Negative symptomsa (PANSS) −0.21 (p = 0.83) 0.986a [0.870–1.119]a ES =−0.03 0.47 (p = 0.63) 1.031a [0.908–1.172]a ES = 0.08
Disorganised symptomsa
(PANSS)
1.28 (p = 0.20) 1.073a [0.964–1.194]a ES = 0.20 1.81 (p = 0.07) 1.106a [0.992–1.233]a ES = 0.28
aOutcome was analysed on the ln-scale due to positive skewness. Unstandardised effect estimates represent multiplicative (factor) effects and need to be compared with the factor
value ‘1’ (=no group effect).
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of approximately two sessions per week is consistent
with attendance rates in our previous trials, which
have generally used extended time periods to achieve
a higher dose (Wykes et al. 2007). One meta-analysis
of CR (McGurk et al. 2007) reported a mean intensity
of 2 hours per week, and this remains a common
regime in CR trials (Bowie et al. 2012; Drake et al.
2014). The persistence of a two session per week
norm, despite the emphasis on massed practice in CR
programmes, may reﬂect the clinical reality that motiv-
ating people with schizophrenia [known to often have
motivational impairments (Cella et al. 2014)], to attend
more than twice a week is challenging.
Does CIRCuiTS lead to improved cognitive and
functional outcomes?
Both post-therapy and at 3 month follow-up the
CIRCuiTS group showed signiﬁcantly greater
improvement in immediate visual memory. This is
encouraging in light of ﬁndings of deterioration in
visual-spatial/constructional skills over 3 years in a
sample of people with chronic schizophrenia
(Dickerson et al. 2014): CIRCuiTS may protect against
cognitive decline. There was also a trend (p = 0.056)
for greater improvement in WCST scores following
CIRCuiTS, which may be important since this was
the main cognitive driver of functioning improvement.
Changes in other cognitive outcomes were not sign-
iﬁcantly different between groups. We have noted that
the mean number of sessions was lower than intended
and consequently may have been insufﬁcient for con-
sistent cognitive improvements. In fact, greater WCST
and social functioning improvements at post-treatment
were associated with doing more therapy sessions. The
main theoretical change mechanism for CIRCuiTS, in
addition to massed practice, is via the development
of metacognitive knowledge and metacognitive regula-
tion, including the use of strategies for a more system-
atic and organised approach to tasks. Greater
improvement in immediate visual memory was pre-
dicted by a higher mean number of tasks carried out
within sessions and a higher mean number of strat-
egies rated as helpful by patients. This is consistent
with massed practice and strategy use being the chief
mechanisms of cognitive change. However, note that
our study only estimates associations with aspects of
therapy, which are not necessarily causal.
A more strategic approach is likely to entail a consid-
erable shift in the way in which tasks are undertaken,
and this may lead to an initial deterioration in perform-
ance (Harvey et al. 2009). The two cognitive tasks,
which did not show improvement require immediate,
rapid responses, and so would not have been likely
to beneﬁt from an increase in strategic thinking,T
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which may take more time. However, better strategy
use does appear to underpin more efﬁcient executive
and memory performance in schizophrenia in both
the WCST (Choi & Kurtz, 2009) and the ROCF
(Landgraf et al. 2011), consistent with the cognitive
improvements in this study.
To assess functional changes, we used a Time Use
Survey measure in an attempt to capture the wide
range of changes (from gaining paid employment to
beginning to meet with a relative once or twice a
week) that may be meaningful within a sample of peo-
ple with a schizophrenia diagnosis. CIRCuiTS led to
improved community functioning post-therapy by
increasing the hours spent in structured activity,
although this was not sustained at follow-up. This pre-
sumably reﬂects the constraints of offering therapy
within a research context. For many people, sustained
improvement and recovery requires maintained sup-
port. This is consistent with ﬁndings that CR is most
beneﬁcial when offered in the context of an adjunctive
rehabilitation programme (Wykes et al. 2011).
Does cognition mediate improvements in
functioning?
Only improved executive functioning was associated
with beneﬁts for functioning: this ﬁnding is well-
supported in the literature (Reeder et al. 2006, 2014;
Eack et al. 2009; Wykes et al. 2012) and is consistent
with the metacognitive model, which underpins
CIRCuiTS (Wykes & Reeder, 2005). Executive func-
tions are likely to be important CR targets to achieve
functional change. However, note that we cannot
establish causality at this stage. Our mediation models
were exploratory in nature and make a number of
assumptions; including that there are no further hid-
den confounders of the cognition-functioning relation-
ship and that measurement error in cognitive variables
is negligible.
Study limitations
Despite being one of the largest CR trials to date, our
ﬁnal sample size might have been too low to identify
moderate effects at the 5% signiﬁcance level taking
into account our multiple outcome comparisons.
Consequently, we may have failed to detect some
effects of CIRCuiTS.
We did not include an active control condition: a
lack of agreement regarding what constitutes speciﬁc
v. non-speciﬁc effects of CR, combined with evidence
that active computerised CR controls may not be
effective (Gomar et al. 2015), made it difﬁcult to justify
public funding support for an additional control treat-
ment arm.
Conclusions
CIRCuiTS, a new generation computerised CR pro-
gramme, is feasible to deliver both with therapist-led
and independent sessions. It led to improved perform-
ance in immediate visual memorywhich relies on execu-
tive organisational skills for effective encoding, and this
improvement was maintained at 3-month follow-up. It
also resulted in increased structured activity post-
therapy. A large-scale effectiveness trial is warranted.
Supplementary material
The supplementary material for this article can be
found at https://doi.org/10.1017/S0033291717001234.
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